| Code | 1381F | ||||||||||
| MA number | 44/0351/25-S | ||||||||||
| Product Form: | tbl flm 30x250 mg (blis.Al/PVC/PE/PVDC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | AGmed s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 10.10.2025 |
| Validity: | 10.10.2030 |
| SPC: |
SPC_Abiraterone AGmed 250 mg_tbl flm_10/2025_REG.pdf
|
| PIL: |
PIL_Abiraterone AGmed 250 mg_tbl flm_10/2025_REG.pdf
|
| Safety feature | Yes |
| Data update: | 20.10.2025 |
